EP Patent

EP0684254A1 — Propiophenone derivative and a process for preparing the same

Assigned to Tanabe Pharma Corp · Expires 1995-11-29 · 30y expired

What this patent protects

A propiophenone derivative of the formula [I]: wherein X is O, S or methylene, OY is a protected or unprotected OH, Z is β-D-glucopyranosyl or 4-O-(α-D-glucopyranosyl)-β-D-glucopyranosyl or wherein one or more hydroxy groups of these groups may optionally be acylated, an…

USPTO Abstract

A propiophenone derivative of the formula [I]: wherein X is O, S or methylene, OY is a protected or unprotected OH, Z is β-D-glucopyranosyl or 4-O-(α-D-glucopyranosyl)-β-D-glucopyranosyl or wherein one or more hydroxy groups of these groups may optionally be acylated, and the dotted line means the presence or absence of a double bond, or a pharmaceutically acceptable salt thereof. Said compounds have excellent hypoglycemic activity so that they are useful in the prophylaxis or treatment of diabetes.

Drugs covered by this patent

Patent Metadata

Patent number
EP0684254A1
Jurisdiction
EP
Classification
—
Expires
1995-11-29
Drug substance claim
No
Drug product claim
No
Assignee
Tanabe Pharma Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.